Home › Funds › Geode Capital Management › STRO
Geode Capital Management position in STRO
SUTRO BIOPHARMA INC · Health Care
Latest position (Q2 2026)389.69K sh
Reported value held$12.94M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 691.98K | $13.07M | New |
| Q4 2021 | 743.68K | $11.06M | Add |
| Q1 2022 | 788.80K | $6.48M | Add |
| Q2 2022 | 814.79K | $4.25M | Add |
| Q3 2022 | 850.75K | $4.72M | Add |
| Q4 2022 | 1.02M | $8.25K | Add |
| Q1 2023 | 1.06M | $4.88M | Add |
| Q2 2023 | 1.16M | $5.40M | Add |
| Q3 2023 | 1.20M | $4.15M | Add |
| Q4 2023 | 1.26M | $5.40M | Add |
| Q1 2024 | 1.29M | $7.27M | Add |
| Q2 2024 | 1.72M | $5.05M | Add |
| Q3 2024 | 1.86M | $6.43M | Add |
| Q4 2024 | 1.85M | $3.41M | Hold |
| Q1 2025 | 1.89M | $1.23M | Add |
| Q2 2025 | 816.91K | $583.41K | Reduce |
| Q3 2025 | 820.95K | $713.19K | Hold |
| Q4 2025 | 83.98K | $971.99K | Reduce |
| Q1 2026 | 171.39K | $4.27M | Add |
| Q2 2026 | 389.69K | $12.94M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding STRO
- BlackRock Inc 1.12M sh · $37.27M · Q2 2026
- Balyasny Asset Management 711.16K sh · $23.61M · Q2 2026
- Millennium Management 365.97K sh · $12.15M · Q2 2026
- Point72 Asset Management 237.83K sh · $7.90M · Q2 2026
- UBS Group AG 208.51K sh · $6.92M · Q2 2026
- Two Sigma Investments 201.69K sh · $6.70M · Q2 2026
- Marshall Wace 175.25K sh · $5.82M · Q2 2026
- JPMorgan Chase & Co 159.63K sh · $5.32M · Q2 2026
- Goldman Sachs Group 149.22K sh · $4.95M · Q2 2026
- Vanguard Group 375.79K sh · $4.35M · Q4 2025
- Northern Trust Corp 125.93K sh · $4.18M · Q2 2026